There wasn't a lot of fanfare around Masimo's $40 million cash offer for Lidco on Monday, but medtech analysts commenting on the deal announcement seem to think the hemodynamic monitoring tuck-in is a good fit.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,